Aktie A0M4EL KPC PHARMACEUTICALS,INC
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen KPC Pharmaceuticals,Inc

Aktien

A0M4EL

CNE0000015P8

600422

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 30.04.2024 		% 5 Tage % 1. Jan.
22,72 CNY -0,66 % Intraday Chart für KPC Pharmaceuticals,Inc +8,76 % +8,92 %
19.04. KPC Pharmaceuticals,Inc berichtet über die Ergebnisse für das erste Quartal bis zum 31. März 2024 CI
21.03. KPC Pharmaceuticals,Inc schlägt Bardividende vor CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024
Kunyao Group Receives Clinical Trial Approval for FMF Drug
KPC Pharmaceuticals,Inc Proposes Cash Dividend
KPC Pharmaceuticals,Inc Reports Earnings Results for the Full Year Ended December 31, 2023
KPC Pharmaceuticals,Inc Reports Earnings Results for the Nine Months Ended September 30, 2023
KPC Pharmaceuticals’ Antimalarial Drug Passes WHO Prequalification
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%
KPC Pharmaceuticals,Inc Reports Earnings Results for the Half Year Ended June 30, 2023
KPC Pharmaceuticals' Q1 Net Profit Jumps; Shares Rise 7%
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
KPC Pharma’s Shingles Drug Added to China’s Medical Insurance Catalog
KPC Pharma to Hold Phase II Clinical Trial of Stroke Drug
China Resources Pharmaceutical Completes Transfer of KPC Pharmaceutical Shares to Unit
KPC Pharmaceuticals CFO Steps Down
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of a 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited.
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
KPC Pharmaceuticals Unit Receives Marketing Authorization of Angong Niuhuang Pills; Shares Jump 7%
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Chinese Shares Rebound; KPC Pharma Rallies 10% on CR Sanjiu’s $431 Million Stake Purchase
CR Sanjiu Medical & Pharma to Buy 28% Stake in KPC Pharma For $430 Million
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4EL Aktie
  4. Nachrichten KPC Pharmaceuticals,Inc
  5. Andere Sprachen